S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NYSE:BME

BlackRock Health Sciences Trust - BME Stock Forecast, Price & News

$44.16
-0.70 (-1.56%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$44.16
$45.02
50-Day Range
$38.85
$44.88
52-Week Range
$38.27
$48.99
Volume
26,756 shs
Average Volume
37,579 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
0.06%
Price Target
N/A
BME stock logo

About BlackRock Health Sciences Trust (NYSE:BME) Stock

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

BME Stock News Headlines

See More Headlines
Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

BME Company Calendar

Ex-Dividend for 11/30 Dividend
11/14/2022
Dividend Payable
11/30/2022
Today
12/09/2022
Ex-Dividend for 12/30 Dividend
12/15/2022
Dividend Payable
12/30/2022

Industry, Sector and Symbol

Industry
Closed - End Fund - Equity
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Charles Choon Sik Park (Age 55)
    Chief Compliance Officer and Anti-Money Laundering Officer
  • Mr. Thomas P. Callan C.F.A.
    Portfolio Mang.
  • Mr. Kyle G. McClements C.F.A.
    CFA, Portfolio Mang.
  • Dr. Erin Xie Ph.D. (Age 54)
    Portfolio Mang.
  • Mr. Christopher M. Accettella
    Portfolio Mang.
  • Mr. Jeffrey Gene Lee
    Portfolio Mang.
  • Dr. Xiang Liu Ph.D.
    Portfolio Mang.













BME Stock - Frequently Asked Questions

How have BME shares performed in 2022?

BlackRock Health Sciences Trust's stock was trading at $48.50 at the start of the year. Since then, BME stock has decreased by 8.9% and is now trading at $44.16.
View the best growth stocks for 2022 here
.

Are investors shorting BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 46,900 shares, an increase of 45.7% from the October 31st total of 32,200 shares. Based on an average trading volume of 36,100 shares, the short-interest ratio is currently 1.3 days.
View BlackRock Health Sciences Trust's Short Interest
.

How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust announced a monthly dividend on Tuesday, December 6th. Investors of record on Friday, December 16th will be paid a dividend of $0.213 per share on Friday, December 30th. This represents a $2.56 annualized dividend and a dividend yield of 5.79%. The ex-dividend date is Thursday, December 15th.
Read our dividend analysis for BME
.

Is BlackRock Health Sciences Trust a good dividend stock?

BlackRock Health Sciences Trust (NYSE:BME) pays an annual dividend of $2.40 per share and currently has a dividend yield of 0.06%.
Read our dividend analysis for BME.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Procter & Gamble (PG).

What is BlackRock Health Sciences Trust's stock symbol?

BlackRock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's stock is owned by many different institutional and retail investors. Top institutional investors include Nova R Wealth Inc. (0.00%), UBS Group AG (0.00%), Royal Bank of Canada (0.00%), Cornerstone Advisory LLC (0.00%), Cambridge Investment Research Advisors Inc. (0.00%) and Janney Montgomery Scott LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BlackRock Health Sciences Trust's stock price today?

One share of BME stock can currently be purchased for approximately $44.16.

How can I contact BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The official website for the company is www2.blackrock.com. The company can be reached via phone at (800) 882-0052.

This page (NYSE:BME) was last updated on 12/9/2022 by MarketBeat.com Staff